DZIF scientists Frauke Mücksch and Angelique Hölzemer on stage with Marc Franke, one of the few people cured of HIV, during a panel discussion at the AIDS 2024 conference in Munich. Ralf Derazzi and Alecia Tramel-McIntyre, from the "HOPE Collaboratory", moderated the discussion).

Why are communities key to research—and why does language matter in science?

Watch DZIF scientists and Marc Franke, one of the few cured of #HIV & DZIF Patient Advisory Board member, in a talk from #AIDS2024 in Munich. 🎤📺

▶️ t1p.de/a3p82

@fraukemuecksch.bsky.social @raifderrazi.bsky.social

🎥 #IAS2025 may be over, but you can watch over 500 past conference sessions from #AIDS2022, #IAS2023, #AIDS2024 and #HIVR4P2024 on #IASPlus for free!

🔎 Search sessions by topic, speaker and more: zurl.co/usOWA

Discontinuing AIDS funding could trigger 4 million deaths by 2029, says new report: What are implications for India? International assistance accounts for 80 per cent of prevention programmes in low- and middle-income countries

"Discontinuing #AIDS funding could trigger 4 million deaths by 2029, says new report: What are implications for #India?"

Anuradha Mascarenhas, an #AIDS2024 media scholar, explores this question in @indianexpress.com 👇

Blockchain, HIV and big ideas from the ground up Some of blockchain's core principles are deeply practical in global health settings, and these new technologies should be explored.

📲 Check out this new blog by Marina Smelyanskaya who explores the powerful potential of #Web3 & #blockchain technologies in the #HIV response, a topic she and colleagues from UNDP Europe and Central Asia presented at #AIDS2024!

What are they up to now? Stories of change of AIDS 2024 scholarship alumni

🌍 #AIDS2024 scholarship alumni are turning opportunity into impact — leading, innovating and driving change in the global #HIV response.

📖 Read the inspiring stories of four alumni from #Brazil, #Ethiopia, #Nigeria and the #UK!

What are they up to now? Stories of change of AIDS 2024 scholarship alumni

🌍 In July 2024, 865 #HIV professionals from 101 countries attended #AIDS2024 through IAS-funded scholarships.

Since then, they’ve been transforming new knowledge into impact. We caught up with 4 alumni.

👥 Read their powerful stories of change, creativity & innovation!

🌍 As we gear up for #IAS2025 in Kigali, Rwanda, and virtually from 13 to 17 July, we want to take a moment to reflect on key insights from #AIDS2024!

📰 If you haven't read it yet, check out the AIDS 2024 Conference report: zurl.co/hyj2l

New ways for the next wave: Innovative R&D for the future of women's prevention | IAS Plus Session chair(s): Imelda Mahaka (Zimbabwe); Sharon Hillier (United States).

"New ways for the next wave: Innovative R&D for the future of women's prevention"

▶️ As we mark #WomensDay, check out a replay of this #AIDS2024 session!

#InternationalWomensDay #IWD2025

🗣️ Looking for resources in #Arabic, #French, #Portuguese, #Russian or #Spanish to support your work in the #HIV response?

▶️ Check out over 60 translated #AIDS2024 sessions on #IASPlus:

plus.iasociety.org/search/resou...

🚨 𝗢𝘂𝗿 𝗣𝗿𝗶𝗼𝗿𝗶𝘁𝗶𝗲𝘀 𝗔𝗿𝗲 𝗖𝗹𝗲𝗮𝗿 🔊

@iasociety.bsky.social #AIDS2024 I spoke to @unaids.org & emphasized that, as young people 𝘄𝗲 𝗮𝗿𝗲 𝗻𝗼𝘁 𝗮 𝗼𝗻𝗲 𝘀𝗶𝘇𝗲 𝗳𝗶𝘁𝘀 𝗮𝗹𝗹 & we deserve 𝗵𝗲𝗮𝗹𝘁𝗵 𝘀𝗲𝗿𝘃𝗶𝗰𝗲𝘀 that are 𝘆𝗼𝘂𝘁𝗵-𝗳𝗿𝗶𝗲𝗻𝗱𝗹𝘆, 𝗮𝗰𝗰𝗲𝘀𝘀𝗶𝗯𝗹𝗲 & 𝗶𝗻𝗰𝗹𝘂𝘀𝗶𝘃𝗲—𝗻𝗼 𝗲𝘅𝗰𝘂𝘀𝗲𝘀

We 𝗿𝗲𝗳𝘂𝘀𝗲 policies, services and resources that exclude us

“Diversity was celebrated, and the Pavilion really put people first, not only in Canada but globally,”

Thanks to Martin for attending #AIDS2024 with us! www.aidscanada.ca/_files/ugd/f...

Julez attended #AIDS2024 with us and brought great insights!

“One of the most exciting aspects of the conference was the mixture of people and perspectives represented. Exchanging ideas with everyone really energized me!” www.aidscanada.ca/_files/ugd/f...

Thank you to Renée for attending #AIDS2024 with us!

“The conference broadened my perspectives. I left with fresh insights and updates from global experts.” www.aidscanada.ca/_files/ugd/f...

🗓️ Join us today at 15:00 CET for a youth-led reflection on #AIDS2024 & #HIVR4P2024.

✅ Register now for this #webinar showcasing youth perspectives, leadership, & the latest advancements in #HIV prevention & care for adolescent & young key populations!

bit.ly/4j2GBvb

🌐 Join us tomorrow (Tuesday, 21 January) at 15:00 CET for a youth-led reflection on #AIDS2024 & #HIVR4P2024!

✅ Register now for this free #webinar showcasing youth perspectives, leadership, & the latest advancements in #HIV prevention & care for adolescent & young key populations: bit.ly/4j2GBvb

"Making sure everybody in the community is empowered is perhaps one of the things that will take us to the finish line."

From my interview with Dr. Nkengasong for @iasociety.bsky.social at #AIDS2024.

@www.iasociety.org/podcast/15-sustaining-hi...

Meet Martin from the Positive Leadership Development Institute. Thank you to Martin for attending #AIDS2024 with us and for being a Pavilion Representative at the Canada Pavilion! www.aidscanada.ca/_files/ugd/f...

🙋🏿 Did you know you can access cutting-edge research from #AIDS2024 in Arabic, French, Portuguese, Russian and Spanish?

▶️ Watch these translated sessions for free now on IAS+!

plus.iasociety.org/search/resou...

Science’s 2024 Breakthrough of the Year: Opening the door to a new era of HIV prevention A drug with a novel mechanism protects people against the AIDS virus for 6 months. It could speed the end of the epidemic—if those who need it most get access

👏 @science.org names #lenacapavir its “2024 Breakthrough of the Year”.

We're proud to have provided a platform for this HIV prevention option. PURPOSE 1 full trial results were shared at #AIDS2024 & new data from PURPOSE 2 trial were presented at #HIVR4P2024. www.science.org/content/arti...

Substance Use Disorder and HIV/AIDS: Addressing Dual Crises At AIDS 2024 in July, Kelly Dyer, MD, Perelman School of Medicine, presented research findings from an investigation at the intersection of health equity, substance use detox, infectious disease scree...

www.ajmc.com/view/substan...

Re-posting an interview about work I am proud of from #AIDS2024. My one and only Twitter post…

AIDS 2024: Decriminalizing Sex Work is a Human Rights Imperative Olivia Cordingley Looking back on the many topics raised at AIDS 2024 last week, one panel which took place in the Sex Worker Networking Zone of the Global Village stands out. The discussion, which…

"Decriminalizing sex work will contribute to safer, healthier, and more just societies globally."
Read this summary of our panel at #AIDS2024 co-hosted with NSWP here: buff.ly/475spf5

CRISPR HIV Gene Therapy Disappoints in Early Study EBT-101 recipients who stopped antiretrovirals experienced HIV rebound, but similar therapies may hold promise for herpes and hepatitis B.

News from #AIDS2024: Rachel Presti provides update on CRISPR gene therapy for an #HIV cure, showing that Excision Bio's EBT-101 does not prevent viral rebound, but one study participant had delayed rebound, suggesting it may play a role in remission for some people.
www.poz.com/article/cris...

International Health Conferences Must Avoid Countries That Reject Delegates Linda Joseph Robert’s visa to attend the International AIDS Conference was rejected by Germany. He highlights the cost to the HIV movement when delegates from the global south are discriminated against.

Linda Joseph Robert wurde von der deutschen Botschaft in Uganda ohne triftigen Grund ein Visum verweigert und konnte deshalb - wie andere aus dem Globalen Süden auch - nicht in Präsenz an der Internationalen #Aids- Konferenz #AIDS2024 in München teilnehmen. Solche Fälle sind inakzeptabel.

Ending AIDS as a public health threat is within reach, but we all must act.

@GileadSciences MUST make make generics of lenacapavir available for all of Africa, Asia and Latin America.

#GileadForGood #AIDS2024

WHO recommends long-acting cabotegravir for HIV prevention The World Health Organization (WHO) today released new guidelines  for the use of long-acting injectable cabotegravir (CAB-LA) as pre-exposure prophylaxis (PrEP) for HIV and called for countries to co...

🧵1️⃣ Auf der Intern. #Aids- Konferenz #AIDS2024 in München wurde viel über die medikamentöse #HIV- Prophylaxe #PrEP mit der #Lenacapavir- Depotspritze (alle 6 Monate) gesprochen, auch wenn das Medikament dazu noch gar nicht zugelassen ist. Bereits zugelassen ist die 2-Monats-Spritze mit #Cabotegravir.

Screenshot eines Posts der International @AIDS_conference auf "X"; ein Bild zeigt Rita Süssmuth auf der 25. Internationalen Aids-Konferenz #AIDS2024. Text: "Human beings are much more powerful than you believe.. You sitting here today, you are our hope."

Zum Abschluss der 25. Internationalen #Aids- Konferenz #AIDS2024 in München sprach auch Rita Süssmuth. Ihr hat die Aidshilfebewegung und haben die Menschen mit HIV und Aids in Deutschland viel zu verdanken. "Menschen können viel mehr erreichen als man denkt. Sie alle hier, Sie sind unsere Hoffnung".

#AIDS2024 "Als lesbische Frau aus Lateinamerika und Direktorin der ersten Klinik für sexuelle und geschlechtliche Minderheiten in Rio de Janeiro erlebe ich jeden Tag aus erster Hand, wie wir immer noch bei den am stärksten marginalisierten Menschen versagen." Beatriz Grinsztejn, neue IAS-Präsidentin

Beatriz Grinsztejn of Brazil is the new President of the International AIDS Society

🧵1️⃣ Beatriz Grinsztejn aus Brasilien ist neue Präsidentin der Internationalen #Aids- Gesellschaft IAS. Dies gab die IAS zum Abschluss der 25. Internationalen Aids-Konferenz #AIDS2024 in München bekannt.

Screenshot eines Posts der International AIDS Conference auf "X"; Text: “We did a great disservice to #PrEP by selling it as something for people who are ‘high risk’. People are not ‘high risk’. They are in an environment where they are exposed to HIV.”

#AIDS2024 Bei der Indikation für die medikamentöse #HIV- Prophylaxe #PrEP spricht man meist - auch in D - von erhöhtem HIV-Risiko. Susan Buchbinder sagt, damit habe man potenziellen Nutzer*innen geschadet. "Sie haben kein erhöhtes Risiko. Sie sind in einer Umgebung, in der sie HIV ausgesetzt sind."

Screenshots eines UNAIDS-Posts auf "X"; Text: Kudos to @MSF_access campaigners for pressing companies on affordable prices for tests so more people can be diagnosed quickly and receive immediate treatment. Make life-saving diagnostics affordable & accessible!

#AIDS2024: UNAIDS unterstützt die #TimeFor5-Kampagne www.msfaccess.org/time-for-5, um Firmen zu erschwinglichen Tests z.B. auf #HIV oder Tuberkulose zu bringen. So können wir mehr Menschen schnell diagnostizieren und in Behandlung bringen - das rettet Leben und unterbricht auch Übertragungsketten!